Susquehanna Portfolio Strategies’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5M Hold
99,795
0.04% 443
2025
Q4
$2.63M Buy
99,795
+15,600
+19% +$340K 0.04% 442
2025
Q3
$1.44M Sell
84,195
-1,533
-2% -$21.9K 0.02% 586
2025
Q2
$1.08M Buy
+85,728
New +$1.02M 0.02% 491
2024
Q4
Sell
-24,671
Closed -$310K 336
2024
Q3
$310K Hold
24,671
0.02% 286
2024
Q2
$210K Sell
24,671
-2,526
-9% -$22.5K 0.01% 459
2024
Q1
$286K Hold
27,197
0.01% 678
2023
Q4
$283K Buy
+27,197
New +$217K 0.01% 872

Other funds holding ZYME

Susquehanna Portfolio Strategies's ZYME Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Zymeworks (ZYME) position steady in Q1 2026 at 99,795 shares worth $2.5M. The position accounts for 0.04% of the portfolio, ranked #443.

Susquehanna Portfolio Strategies first reported a position in ZYME in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.63M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Susquehanna Portfolio Strategies held 99,795 shares of Zymeworks worth $2.5M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #443 holding.
  • Susquehanna Portfolio Strategies first reported a position in Zymeworks in Q4 2023 and has held it in 8 quarters since.
  • Susquehanna Portfolio Strategies's Zymeworks position peaked at $2.63M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.